- +170.6% price growth over the last year
- +70.4% YTD performance
- Lower volatility than the market (beta 0.22)
CG Oncology, Inc. stock price ended at $71.19 on Friday, after losing 2.52%
(Updated on Jul 31, 2026)
The CG Oncology, Inc. stock price fell by -2.52% on the last day (Friday, 31st Jul 2026) from $73.03 to $71.19. During the last trading day the stock fluctuated 4.80% from a day low at $69.60 to a day high of $72.94. The price has fallen in 6 of the last 10 days and is down by -0.92% for this period. Volume has increased on the last day by 42 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 561 thousand shares were bought and sold for approximately $39.92 million.
The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 12.64% during the next 3 months and, with a 90% probability hold a price between $66.61 and $87.16 at the end of this 3-month period.
CGON Signals & Forecast
A sell signal was issued from a pivot top point on Friday, July 10, 2026, and so far it has fallen -5.38%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely. Some positive signals were issued as well, and these may have some influence on the near short-term development. The CG Oncology, Inc. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $71.42. On a fall, the stock will find some support from the long-term average at approximately $69.05. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal.
Support, Risk & Stop-loss for CG Oncology, Inc. stock
CG Oncology, Inc. finds support from accumulated volume at $68.72 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $3.34 (4.80%) between high and low. For the last week, the stock has had daily average volatility of 6.53%.
Our recommended stop-loss: $68.64 (-3.58%) (This stock has low daily movements and this gives low risk. There is a sell signal from a pivot top found 15 days ago.)
Trading Expectations (CGON) For The Upcoming Trading Day Of Monday 3rd
For the upcoming trading day on Monday, 3rd we expect CG Oncology, Inc. to open at $71.24, and during the day (based on 14 day Average True Range), to move between $69.23 and $73.15, which gives a possible trading interval of +/-$3.93 (+/-5.67%) up or down from last closing price. If CG Oncology, Inc. takes out the full calculated possible swing range there will be an estimated 5.67% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $71.96 (1.08%) than the support at $68.72 (3.47%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Earnings coming up
CG Oncology, Inc. will release earnings BMO on Friday, August 07, 2026.The consensus among the analysts for the expected earnings (EPS) is -$0.700. We will update the financials statements for CG Oncology, Inc., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 6.43% in the first trading day after earnings release.
Is CG Oncology, Inc. stock A Buy?
Several of the signals/indicators are negative, and we believe that this will affect on the development for the next days and maybe possible weeks. However, over time, we think that today's level holds a possible buying opportunity and that the price will be higher during or at the end of this 3-month period.
Current score:
2.424
Buy Candidate
Unchanged
Predicted Fair Opening Price
Predicted fair opening price on August 3, 2026 - $71.24 ( 0.0759%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
CGON Performance
Trading levels for CGON
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 74.58 | 4.76% |
| R2 | 73.31 | 2.97% |
| R1 | 72.52 | 1.87% |
| Price | 71.19 | |
| S1 | 69.97 | -1.72% |
| S2 | 69.18 | -2.82% |
| S3 | 67.91 | -4.61% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 72.84 | 2.32% |
| R2 | 72.62 | 2.01% |
| R1 | 71.96 | 1.08% |
| Price | 71.19 | |
| S1 | 68.72 | -3.47% |
| S2 | 61.89 | -13.06% |
| S3 | 61.08 | -14.20% |
FAQ
Click here for our free guide on how to buy CG Oncology, Inc. Stock.
Buy CGON